Balasa Dinverno & Foltz’s Chemed CHE Stock Holding History

Balasa Dinverno & Foltz’s Portfolio CHE Stock Details CHE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-617	Closed	-$271K	–	256
2019 Q4	$271K	Buy	617 +106	+21%	+$44.6K	0.03%	221
2019 Q3	$213K	Buy	+511	New	+$209K	0.02%	238

Other funds holding CHE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Balasa Dinverno & Foltz's CHE Position: Q1 2020 in Review

Balasa Dinverno & Foltz sold out of Chemed (CHE) in Q1 2020, closing a stake of 617 shares — an estimated $271K sold.

Balasa Dinverno & Foltz first reported a position in CHE in Q3 2019 and held it in 2 quarters. The position peaked at $271K in Q4 2019. 412 funds tracked by Wall St. Rank hold CHE as of Q1 2020.

Balasa Dinverno & Foltz reported no remaining Chemed position as of Q1 2020 after selling out during the quarter.
Balasa Dinverno & Foltz sold 617 Chemed shares in Q1 2020, an estimated $271K.
Balasa Dinverno & Foltz first reported a position in Chemed in Q3 2019 and held it in 2 quarters.
Balasa Dinverno & Foltz's Chemed position peaked at $271K in Q4 2019.
412 funds tracked by Wall St. Rank held Chemed as of Q1 2020.

Based on Balasa Dinverno & Foltz's 13F filing for Q1 2020, filed 30 Apr 2020.